Aspiriant LLC’s Sempra SRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $269K | Sell |
2,900
-2,444
| -46% | -$227K | 0.01% | 336 |
|
|
2026
Q1 | $519K | Buy |
+5,344
| New | +$489K | 0.01% | 215 |
|
|
2025
Q1 | – | Sell |
-2,548
| Closed | -$224K | – | 302 |
|
|
2024
Q4 | $224K | Sell |
2,548
-108
| -4% | -$9.45K | 0.01% | 269 |
|
|
2024
Q3 | $222K | Buy |
+2,656
| New | +$212K | 0.01% | 267 |
|
|
2023
Q2 | – | Sell |
-5,990
| Closed | -$453K | – | 294 |
|
|
2023
Q1 | $453K | Buy |
5,990
+1,742
| +41% | +$134K | 0.02% | 185 |
|
|
2022
Q4 | $328K | Buy |
4,248
+2
| +0% | +$155 | 0.02% | 208 |
|
|
2022
Q3 | $318K | Sell |
4,246
-12
| -0.3% | -$971 | 0.02% | 206 |
|
|
2022
Q2 | $320K | Sell |
4,258
-824
| -16% | -$66.2K | 0.02% | 205 |
|
|
2022
Q1 | $427K | Sell |
5,082
-528
| -9% | -$37.9K | 0.02% | 189 |
|
|
2021
Q4 | $371K | Buy |
5,610
+1,470
| +36% | +$93.2K | 0.02% | 204 |
|
|
2021
Q3 | $262K | Buy |
4,140
+34
| +0.8% | +$2.24K | 0.02% | 206 |
|
|
2021
Q2 | $272K | Sell |
4,106
-346
| -8% | -$23.7K | 0.02% | 208 |
|
|
2021
Q1 | $295K | Sell |
4,452
-70
| -2% | -$4.35K | 0.02% | 182 |
|
|
2020
Q4 | $287K | Buy |
4,522
+138
| +3% | +$8.88K | 0.02% | 174 |
|
|
2020
Q3 | $259K | Buy |
4,384
+44
| +1% | +$2.71K | 0.02% | 189 |
|
|
2020
Q2 | $254K | Sell |
4,340
-8
| -0.2% | -$492 | 0.02% | 165 |
|
|
2020
Q1 | $245K | Buy |
4,348
+72
| +2% | +$5.11K | 0.02% | 167 |
|
|
2019
Q4 | $324K | Buy |
4,276
+12
| +0.3% | +$880 | 0.03% | 166 |
|
|
2019
Q3 | $315K | Buy |
4,264
+44
| +1% | +$3.08K | 0.03% | 172 |
|
|
2019
Q2 | $290K | Buy |
4,220
+32
| +0.8% | +$2.1K | 0.02% | 182 |
|
|
2019
Q1 | $264K | Buy |
4,188
+28
| +0.7% | +$1.65K | 0.02% | 197 |
|
|
2018
Q4 | $225K | Sell |
4,160
-662
| -14% | -$37.7K | 0.02% | 210 |
|
|
2018
Q3 | $274K | Sell |
4,822
-3,196
| -40% | -$185K | 0.02% | 203 |
|
|
2018
Q2 | $465K | Sell |
8,018
-68
| -0.8% | -$3.72K | 0.04% | 164 |
|
|
2018
Q1 | $450K | Buy |
+8,086
| New | +$436K | 0.04% | 160 |
|
|
2017
Q4 | – | Sell |
-4,676
| Closed | -$267K | – | 167 |
|
|
2017
Q3 | $267K | Buy |
4,676
+34
| +0.7% | +$1.97K | 0.02% | 174 |
|
|
2017
Q2 | $262K | Buy |
4,642
+34
| +0.7% | +$1.92K | 0.02% | 182 |
|
|
2017
Q1 | $255K | Sell |
4,608
-268
| -5% | -$14.2K | 0.02% | 184 |
|
|
2016
Q4 | $245K | Buy |
4,876
+334
| +7% | +$17K | 0.02% | 171 |
|
|
2016
Q3 | $243K | Buy |
+4,542
| New | +$247K | 0.02% | 172 |
|
Other funds holding SRE
Aspiriant LLC's SRE Position: Q2 2026 in Review
Aspiriant LLC reduced its Sempra (SRE) stake by 46% in Q2 2026, selling an estimated $227K and leaving 2,900 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #336.
Aspiriant LLC first reported a position in SRE in Q3 2016 and has held it in 30 quarters since. The position peaked at $519K in Q1 2026. 1,282 funds tracked by Wall St. Rank hold SRE as of Q2 2026.
- Aspiriant LLC held 2,900 shares of Sempra worth $269K as of Q2 2026.
- Aspiriant LLC sold 2,444 Sempra shares in Q2 2026, an estimated $227K.
- Sempra made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #336 holding.
- Aspiriant LLC first reported a position in Sempra in Q3 2016 and has held it in 30 quarters since.
- Aspiriant LLC's Sempra position peaked at $519K in Q1 2026.
- 1,282 funds tracked by Wall St. Rank held Sempra as of Q2 2026.
Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.